Enokizumab

**Semantic type:** Amino Acid, Peptide, or Protein|Immunologic Factor|Pharmacologic Substance

**Definition:** A humanized monoclonal antibody directed against the cytokine interleukin-9 (IL-9), with potential immunomodulating activity. Upon administration, enokizumab binds to and blocks the activity of IL-9, thereby preventing IL-9-mediated effects. IL-9, a T-helper cell type 2-derived cytokine, is involved in airway inflammation and hyperrreactivity.

**Synonyms:** - 7F3com-2H2 - Anti-IL9 Monoclonal Antibody MEDI-528 - ENOKIZUMAB - MEDI 528